Real-world multicenter assessment of sustained clinical outcomes after digital deep brain stimulation - Takeaways - MDSpire

Real-world multicenter assessment of sustained clinical outcomes after digital deep brain stimulation

  • By

  • Alireza Gharabaghi

  • Sergiu Groppa

  • Elena Casas

  • Alfons Schnitzler

  • Laura Muñoz-Delgado

  • Vicky L. Marshall

  • Jessica Karl

  • Lin Zhang

  • Ramiro Alvarez

  • Mary S. Feldman

  • Michael J. Soileau

  • Lan Luo

  • Benjamin L. Walter

  • Chengyuan Wu

  • Hong Lei

  • Damian M. Herz

  • Devyani Nanduri

  • Claudia A. Salazar

  • Corneliu Luca

  • Daniel Weiss

  • January 14, 2026

  • 0 min

Share

  • 1

    Digital health interventions can enhance healthcare delivery but face unique evaluation challenges in real-world settings.

  • 2

    Deep brain stimulation (DBS) is effective for Parkinson's disease, but optimal outcomes require individualized programming and follow-up.

  • 3

    A multicenter study showed that remote DBS programming led to sustained clinical benefits and patient satisfaction over 6 and 12 months.

  • 4

    Both remote and in-clinic DBS programming resulted in similar improvements in patient-reported outcomes and quality of life.

  • 5

    The study supports the long-term equivalence of remote and in-person care models for managing Parkinson's disease symptoms.

Original Source(s)

Real-world multicenter assessment of sustained clinical outcomes after digital deep brain stimulation

  • by Alireza Gharabaghi, Sergiu Groppa, Elena Casas, Alfons Schnitzler, Laura Muñoz-Delgado, Vicky L. Marshall, Jessica Karl, Lin Zhang, Ramiro Alvarez, Mary S. Feldman, Michael J. Soileau, Lan Luo, Benjamin L. Walter, Chengyuan Wu, Hong Lei, Damian M. Herz, Devyani Nanduri, Claudia A. Salazar, Corneliu Luca, Daniel Weiss

  • January 14, 2026

Related Content

Lorazepam-induced full resolution of catatonia and psychosis in Parkinson’s disease with acromegaly: a case report

Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson’s disease risk

Beyond a syndrome: a mechanism for depression in Parkinson’s disease